On January 4, 2024 AtriCure, Inc. filed a Current Report on Form 8-K reporting that the Company?s Board of Directors elected Shlomi Nachman to serve as a director until the Company?s next Annual Meeting of Stockholders. This Current Report on Form 8-K amends the Original Form 8-K for the purpose of reporting that effective February 22, 2024, the Board elected Mr. Nachman to serve as a member of each of the Board?s Strategy Committee and Compliance, Quality and Risk Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.89 USD | -2.58% | +0.09% | -38.67% |
05-02 | Needham Lowers AtriCure's PT to $40 From $46 Due to Peer Multiple Contraction, Keeps Buy Rating | MT |
05-01 | Earnings Flash (ATRC) ATRICURE Reports Q1 Revenue $108.9M, vs. Street Est of $106.9M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.67% | 1.09B | |
-5.51% | 182B | |
+2.33% | 111B | |
-3.62% | 68.48B | |
+1.52% | 49.69B | |
+8.06% | 44.46B | |
+2.33% | 40.67B | |
+23.35% | 31.22B | |
+0.67% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- ATRC Stock
- News AtriCure, Inc.
- Atricure, Inc. Appoints Shlomi Nachman as Director, Member of Each of the Board?s Strategy Committee and Compliance, Quality and Risk Committee